The incubation technology accelerating CAR-T cell therapy development

20 July 2020

In this video, Dr. Gerhard Bauer, Professor of Hematology and Oncology and Director of the Good Manufacturing Practice (GMP) laboratory at the UC Davis Institute, highlights his current work on the production of CAR-T cells, powerful therapies that use a patient's own immune cells to treat cancer. Key to this work, Bauer’s team uses the MCO-170AICUVDL-PA automatic high heat sterilization CO2 incubator by PHCbi, a precisely calibrated self-sterilizing instrument that, Bauer explains, is critical to ensuring the laboratory’s gene therapy products are safe and contamination-free for patients.